MENU
+Compare
BVS
Stock ticker: NASDAQ
AS OF
Jun 26, 04:59 PM (EDT)
Price
$6.66
Change
-$0.03 (-0.45%)
Capitalization
330.84M

BVS Bioventus Forecast, Technical & Fundamental Analysis

Bioventus Inc is a medical technology company... Show more

BVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BVS with price predictions
Jun 25, 2025

Momentum Indicator for BVS turns negative, indicating new downward trend

BVS saw its Momentum Indicator move below the 0 level on June 25, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 74 similar instances where the indicator turned negative. In of the 74 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BVS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BVS broke above its upper Bollinger Band on June 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 50 cases where BVS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BVS advanced for three days, in of 242 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BVS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.380) is normal, around the industry mean (24.307). P/E Ratio (10.661) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (2.142) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.638) is also within normal values, averaging (42.612).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BVS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
BVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BVS is expected to report earnings to rise 250.00% to 20 cents per share on August 12

Bioventus BVS Stock Earnings Reports
Q2'25
Est.
$0.21
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.07
Q3'24
Missed
by $0.09
Q2'24
Beat
by $0.12
The last earnings report on May 06 showed earnings per share of 5 cents, beating the estimate of 1 cents. With 143.35K shares outstanding, the current market capitalization sits at 330.84M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
4721 Emperor Boulevard
Phone
+1 919 474-6700
Employees
970
Web
https://www.bioventus.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYENX222.18N/A
N/A
Rydex Energy A
TPICX13.79N/A
N/A
Timothy Plan International C
DQICX31.34N/A
N/A
BNY Mellon Equity Income Fund C
AMVRX15.64N/A
N/A
American Century Mid Cap Value R
JFACX36.43N/A
N/A
JHancock Fundamental All Cap Core R2

BVS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BVS has been loosely correlated with OFIX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if BVS jumps, then OFIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVS
1D Price
Change %
BVS100%
-1.04%
OFIX - BVS
53%
Loosely correlated
-0.91%
TCMD - BVS
42%
Loosely correlated
-0.48%
RDNT - BVS
36%
Loosely correlated
+0.57%
CSTL - BVS
36%
Loosely correlated
+1.62%
MMSI - BVS
34%
Loosely correlated
-0.65%
More